Farum, Denmark

Trine Lindsted

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Trine Lindsted: Innovator in Immunotherapy

Introduction

Trine Lindsted is a prominent inventor based in Farum, Denmark. She has made significant contributions to the field of immunotherapy, particularly through her innovative patents. With a total of 4 patents, her work focuses on enhancing immunity and developing therapies for cancer treatment.

Latest Patents

Trine's latest patents include groundbreaking inventions such as anti-FLT3 antibodies and compositions. This invention relates to anti-FLT3 antibodies and methods of using them to enhance immunity in patients and treat cancer. Another notable patent is for combination therapies targeting PD-1, TIM-3, and LAG-3. This disclosure involves therapies that utilize antibodies specific for these targets, aimed at patients who require enhanced immunity. These therapies are particularly useful in treating various cancers.

Career Highlights

Throughout her career, Trine has worked with esteemed companies such as Les Laboratoires Servier and Symphogen A/S. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of immunotherapy.

Collaborations

Trine has collaborated with notable professionals in her field, including Mikkel Wandahl Pedersen and Torben Gjetting. These collaborations have further enriched her research and development efforts.

Conclusion

Trine Lindsted is a remarkable inventor whose work in immunotherapy has the potential to significantly impact cancer treatment. Her innovative patents and collaborations highlight her dedication to enhancing patient immunity and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…